Vincent Perrone | Head-Investor Relations |
Liz Barrett | President and Chief Executive Officer |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Don Kim | Chief Financial Officer |
Leland Gershell | Oppenheimer |
Mitchell Kapoor | HCW |
Matt Kaplan | Ladenburg Thalmann |
Good day and thank you for standing by. And welcome to the UroGen Pharma Q4 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there'll be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.